NCT00258583 Dorothy P. and Richard P. Simmons Center for ILD Research Registry
| NCT ID | NCT00258583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Lung Diseases, Interstitial |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2003-10 |
| Primary Completion | 2035-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2003-10 with a primary completion date of 2035-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to place past, current, and future medical record information into the UPMC Simmons Center for Interstitial Lung Disease Research Registry.
Eligibility Criteria
Inclusion Criteria: * Adult patients who are seeking treatment at the UPMC Simmons Center for Interstitial Lung Disease * 18 years of age or older Exclusion Criteria: * N/A
Contact & Investigator
Kevin F Gibson, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh - UPMC Simmons Center for Interstitial Lung Disease
Frequently Asked Questions
Who can join the NCT00258583 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Diseases, Interstitial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00258583 currently recruiting?
Yes, NCT00258583 is actively recruiting participants. Contact the research team at macphersonmj@upmc.edu for enrollment information.
Where is the NCT00258583 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT00258583 clinical trial?
NCT00258583 is sponsored by University of Pittsburgh. The principal investigator is Kevin F Gibson, MD at University of Pittsburgh - UPMC Simmons Center for Interstitial Lung Disease. The trial plans to enroll 5,000 participants.